Post-translational modification of Fibroblast Growth Factor 23. (Q36216962)

12 August 2017

1 reference

title

Post-translational modification of Fibroblast Growth Factor 23. (English)

1 reference

12 August 2017

Seiji Fukumoto

1

1 reference

12 August 2017

publication date

1 August 2005

1 reference

Therapeutic Apheresis and Dialysis

12 August 2017

published in

1 reference

12 August 2017

volume

9

1 reference

12 August 2017

issue

4

1 reference

12 August 2017

page(s)

319-322

1 reference

Cloning and characterization of an extracellular Ca(2 )-sensing receptor from bovine parathyroid

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111/J.1744-9987.2005.00289.X

Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1744-9987.2005.00289.X

Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1744-9987.2005.00289.X

Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1744-9987.2005.00289.X

Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1744-9987.2005.00289.X

A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. The HYP Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1744-9987.2005.00289.X

Renal transplantation in hypophosphatemia with vitamin D-resistant rickets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1744-9987.2005.00289.X

FGF-23 inhibits renal tubular phosphate transport and is a PHEX substrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1744-9987.2005.00289.X

Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1744-9987.2005.00289.X

FGF23 is processed by proprotein convertases but not by PHEX.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1744-9987.2005.00289.X

Mutant FGF-23 responsible for autosomal dominant hypophosphatemic rickets is resistant to proteolytic cleavage and causes hypophosphatemia in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1744-9987.2005.00289.X

Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1744-9987.2005.00289.X

Mutations in GALNT3, encoding a protein involved in O-linked glycosylation, cause familial tumoral calcinosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1744-9987.2005.00289.X

Congenital disorders of glycosylation: a booming chapter of pediatrics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1744-9987.2005.00289.X

An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1744-9987.2005.00289.X

10.1111/J.1744-9987.2005.00289.X

21 January 2018

Identifiers

DOI

1 reference

12 August 2017

1 reference